Skip to main content
Livermore
Livermore
ZHEN

Emerald Advisers, LLC

SEC CIK
0001015083
Latest filing
Aug 5, 2026

OCUL holding history

Ocular Therapeutix, Inc in every 13F filed by Emerald Advisers, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of OCUL by Emerald Advisers, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−20,768−100.0%Sold outHolders
Q1 202620,768$175.9K<0.1%00.0%UnchangedHolders
Q4 202520,768$252.1K<0.1%00.0%UnchangedHolders
Q3 202520,768$242.8K<0.1%00.0%UnchangedHolders
Q2 202520,768$192.7K<0.1%00.0%UnchangedHolders
Q1 202520,768$152.2K<0.1%00.0%UnchangedHolders
Q4 202420,768$177.4K<0.1%00.0%UnchangedHolders
Q3 202420,768$180.7K<0.1%00.0%UnchangedHolders
Q2 202420,768$142.1K<0.1%00.0%UnchangedHolders
Q1 202420,768$189.0K<0.1%00.0%UnchangedHolders
Q4 202320,768$92.6K<0.1%00.0%UnchangedHolders
Q3 202320,768$65.2K<0.1%−24,949−54.6%ReducedHolders
Q2 202345,717$235.9K<0.1%00.0%UnchangedHolders
Q1 202345,717$240.9K<0.1%−919,524−95.3%ReducedHolders
Q4 2022965,241$2.71M0.1%−541,215−35.9%ReducedHolders
Q3 20221,506,456$6.25M0.3%+40,754+2.8%AddedHolders
Q2 20221,465,702$5.89M0.3%+173,797+13.5%AddedHolders
Q1 20221,291,905$6.39M0.2%+234,178+22.1%AddedHolders
Q4 20211,057,727$7.37M0.3%+208,127+24.5%AddedHolders
Q3 2021849,600$8.50M0.3%−373,900−30.6%ReducedHolders
Q2 20211,223,500$17.3M0.6%−71,350−5.5%ReducedHolders
Q1 20211,294,850$21.2M0.8%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.